Cyclerion Therapeutics (CYCN) Income Statement (2018 - 2026)
Income Statement report data from Mar 31, 2018 to Mar 31, 2026 for Cyclerion Therapeutics (CYCN).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||||||||||
Total Revenue | - | 1.02M (+15.91%) | 880K (+877.78%) | 90K (+12.50%) | 80K (-95.58%) | 1.81M (+852.63%) | 190K | - | - | - | - | - | - | -720.00K | - | 310K (-56.34%) | 710K (+33.96%) | 530K (+51.43%) | 350K (-88.33%) | 3.00M (+4900.00%) | 60K (-53.85%) | 130K (-67.50%) | 400K (-46.67%) | 750K (-25.74%) | 1.01M (-31.76%) | 1.48M (+5.71%) | 1.40M (-14.11%) | 1.63M | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||||||||||
Research And Development | 730K (+40.38%) | 520K (+48.57%) | 350K (+483.33%) | 60K (+50.00%) | 40K (-33.33%) | 60K (-25.00%) | 80K (-27.27%) | 110K (+175.00%) | 40K (+100.00%) | 20K (-96.55%) | 580K (+70.59%) | 340K (-40.35%) | 570K | -15.40M | 1.41M (-86.20%) | 10M (+4.93%) | 9.74M (-6.88%) | 10M (+48.79%) | 7.03M (-41.66%) | 12M (+48.95%) | 8.09M (-33.09%) | 12M (-11.75%) | 14M (-0.65%) | 14M (-18.06%) | 17M (-18.62%) | 21M (-7.26%) | 22M (-13.43%) | 26M (-2.42%) | 26M (+17.59%) | 22M (+4.42%) | 22M (-3.37%) | 22M (+3.44%) | 22M |
Selling General And Administrative | 2.48M (+85.07%) | 1.34M (-12.42%) | 1.53M (-10.53%) | 1.71M (+14.00%) | 1.50M (+20.00%) | 1.25M (+0.81%) | 1.24M (-3.13%) | 1.28M (-18.47%) | 1.57M (-11.30%) | 1.77M (-16.90%) | 2.13M (+39.22%) | 1.53M (-43.33%) | 2.70M (+18.42%) | 2.28M (-26.45%) | 3.10M (-11.93%) | 3.52M (-10.89%) | 3.95M (-10.43%) | 4.41M (-4.13%) | 4.60M (-26.28%) | 6.24M (+16.20%) | 5.37M (-26.13%) | 7.27M (-9.46%) | 8.03M (+21.12%) | 6.63M (-3.77%) | 6.89M (-6.77%) | 7.39M (+3.79%) | 7.12M (-20.18%) | 8.92M (-18.76%) | 11M (+29.94%) | 8.45M (+8.47%) | 7.79M (+3.45%) | 7.53M (+99.73%) | 3.77M |
Operating Expenses | 3.21M (+72.58%) | 1.86M (-1.06%) | 1.88M (+6.21%) | 1.77M (+14.94%) | 1.54M (+18.46%) | 1.30M (-1.52%) | 1.32M (-4.35%) | 1.38M (-14.81%) | 1.62M (-10.00%) | 1.80M (-70.10%) | 6.02M (+221.93%) | 1.87M (-42.99%) | 3.28M | -13.11M | 4.52M (-67.10%) | 14M (+0.29%) | 14M (-7.87%) | 15M (+27.86%) | 12M (-39.36%) | 19M (+42.50%) | 13M (-30.48%) | 19M (-12.71%) | 22M (+8.62%) | 20M (-5.46%) | 22M (-23.05%) | 28M (-4.56%) | 29M (-15.20%) | 35M (-7.22%) | 37M (+20.97%) | 31M (+5.50%) | 29M (-1.65%) | 30M (+17.80%) | 25M |
Depreciation And Amortization | - | - | - | - | - | - | - | - | - | - | - | - | - | 20K | - | - | 50K | -490.00K | 600K (+500.00%) | 100K (-61.54%) | 260K (-44.68%) | 470K (-21.67%) | 600K (0.00%) | 600K (-4.76%) | 630K (-7.35%) | 680K (-2.86%) | 700K (-12.50%) | 800K (+50.94%) | 530K (+43.24%) | 370K (-7.50%) | 400K (0.00%) | 400K (+11.11%) | 360K |
Operating Income | |||||||||||||||||||||||||||||||||
Operating Income | -3.21M (+282.14%) | -840.00K (-16.83%) | -1.01M (-39.52%) | -1.67M (+14.38%) | -1.46M | 500K | -1.13M (-18.12%) | -1.38M (-14.81%) | -1.62M (-10.00%) | -1.80M (-70.05%) | -6.01M (+223.12%) | -1.86M (-43.12%) | -3.27M | 12M | -4.52M (-66.34%) | -13.43M (+3.47%) | -12.98M (-9.48%) | -14.34M (+27.13%) | -11.28M (-30.28%) | -16.18M (+20.84%) | -13.39M (-30.33%) | -19.22M (-11.75%) | -21.78M (+10.73%) | -19.67M (-4.47%) | -20.59M (-22.56%) | -26.59M (-5.10%) | -28.02M (-15.22%) | -33.05M (-11.58%) | -37.38M (+20.97%) | -30.90M (+5.50%) | -29.29M (-1.65%) | -29.78M (+17.80%) | -25.28M |
Ebit | -3.21M (+282.14%) | -840.00K (-16.83%) | -1.01M (-39.52%) | -1.67M (+14.38%) | -1.46M | 500K | -1.13M (-18.12%) | -1.38M (-14.81%) | -1.62M (-10.00%) | -1.80M (-70.05%) | -6.01M (+223.12%) | -1.86M (-43.12%) | -3.27M | 12M | -4.52M (-66.34%) | -13.43M (+3.47%) | -12.98M (-9.48%) | -14.34M (+27.13%) | -11.28M (-30.28%) | -16.18M (+20.84%) | -13.39M (-30.33%) | -19.22M (-11.75%) | -21.78M (+10.73%) | -19.67M (-4.47%) | -20.59M (-22.56%) | -26.59M (-5.10%) | -28.02M (-15.22%) | -33.05M (-11.58%) | -37.38M (+20.97%) | -30.90M (+5.50%) | -29.29M (-1.65%) | -29.78M (+17.80%) | -25.28M |
EBITDA | -3.18M (+297.50%) | -800.00K (-18.37%) | -980.00K (+206.25%) | -320.00K (-77.62%) | -1.43M | 530K | -720.00K (-45.45%) | -1.32M (-14.29%) | -1.54M (-88.21%) | -13.06M | 7.57M | -4.18M (+27.83%) | -3.27M | 18M | -10.50M (-21.58%) | -13.39M (+3.48%) | -12.94M (-12.69%) | -14.82M (+38.76%) | -10.68M (-33.58%) | -16.08M (+22.37%) | -13.14M (-29.92%) | -18.75M (-11.47%) | -21.18M (+11.06%) | -19.07M (-4.46%) | -19.96M (-22.96%) | -25.91M (-5.16%) | -27.32M (-15.29%) | -32.25M (-12.51%) | -36.86M (+20.73%) | -30.53M (+5.68%) | -28.89M (-1.67%) | -29.38M (+17.85%) | -24.93M |
Other Income / Expenses | |||||||||||||||||||||||||||||||||
Other Non Operating Income | 30K (-97.93%) | 1.45M (+4733.33%) | 30K (-97.78%) | 1.35M (+4400.00%) | 30K (-94.74%) | 570K (+39.02%) | 410K (+583.33%) | 60K (-25.00%) | 80K (-77.78%) | 360K (+227.27%) | 110K (+83.33%) | 60K (-33.33%) | 90K (-68.97%) | 290K (+163.64%) | 110K (+120.00%) | 50K (+400.00%) | 10K | -20.00K | - | -10.00K | - | 590K (+555.56%) | 90K (-35.71%) | 140K (-61.11%) | 360K | - | - | - | - | - | - | - | - |
Net Income | |||||||||||||||||||||||||||||||||
Income Before Tax | - | -3.53M | - | - | - | -3.06M | - | - | - | -5.26M | - | - | - | -44.08M | - | - | - | -51.65M | - | - | - | -122.41M | - | - | - | -122.41M | - | - | - | -115.25M | - | - | - |
Net Income From Continuing Operations | -3.18M (+297.50%) | -800.00K (-18.37%) | -980.00K (+206.25%) | -320.00K (-77.62%) | -1.43M | 530K | -720.00K (-45.45%) | -1.32M (-14.29%) | -1.54M (-8.88%) | -1.69M | 7.57M | -4.18M (-39.86%) | -6.95M (-3.74%) | -7.22M (-31.24%) | -10.50M (-21.58%) | -13.39M (+3.16%) | -12.98M (-24.62%) | -17.22M (+52.52%) | -11.29M (-30.22%) | -16.18M (+132.81%) | -6.95M (-63.86%) | -19.23M (+2.23%) | -18.81M (-3.69%) | -19.53M (-3.46%) | -20.23M (-22.37%) | -26.06M (-4.61%) | -27.32M (-15.29%) | -32.25M (-13.72%) | -37.38M (+20.97%) | -30.90M (+5.50%) | -29.29M (-1.65%) | -29.78M (+17.80%) | -25.28M |
Net Income | -3.18M (+297.50%) | -800.00K (-18.37%) | -980.00K (+206.25%) | -320.00K (-77.62%) | -1.43M | 530K | -720.00K (-45.45%) | -1.32M (-14.29%) | -1.54M (-8.88%) | -1.69M | 7.57M | -4.18M (-39.86%) | -6.95M (-3.74%) | -7.22M (-31.24%) | -10.50M (-21.58%) | -13.39M (+3.16%) | -12.98M (-24.62%) | -17.22M (+52.52%) | -11.29M (-30.22%) | -16.18M (+132.81%) | -6.95M (-63.86%) | -19.23M (+2.23%) | -18.81M (-3.69%) | -19.53M (-3.46%) | -20.23M (-22.37%) | -26.06M (-4.61%) | -27.32M (-15.29%) | -32.25M (-13.72%) | -37.38M (+20.97%) | -30.90M (+5.50%) | -29.29M (-1.65%) | -29.78M (+17.80%) | -25.28M |
Comprehensive Income Net Of Tax | -3.18M (-9.92%) | -3.53M (+260.20%) | -980.00K (+206.25%) | -320.00K (-77.62%) | -1.43M (-53.27%) | -3.06M (+325.00%) | -720.00K (-45.45%) | -1.32M (-14.84%) | -1.55M (-70.48%) | -5.25M | 7.56M | -4.18M (-39.86%) | -6.95M (-84.23%) | -44.07M (+319.71%) | -10.50M (-21.58%) | -13.39M (+3.16%) | -12.98M (-74.86%) | -51.64M (+357.40%) | -11.29M (-30.22%) | -16.18M (+20.75%) | -13.40M (-82.78%) | -77.81M (+313.66%) | -18.81M (-3.79%) | -19.55M (-3.36%) | -20.23M (-83.56%) | -123.03M (+350.49%) | -27.31M (-15.34%) | -32.26M (-13.70%) | -37.38M (-67.57%) | -115.25M (+293.48%) | -29.29M (-1.65%) | -29.78M | - |